Gene Cartwright

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Somatogen, Inc. develops specialty oxygen therapeutics. It is engaged in the research, clinical development and commercialization of genetically engineered recombinant human hemoglobin-based products. The company is located in Boulder, CO.

CFM Technologies, Inc. designs, manufactures, and markets advanced wet processing equipment for sale to the worldwide semiconductor industry. The company is based in Exton, PA. CFM Technologies was acquired by Mattson Technology, Inc., a SUB of Beijing Economic & Technology Development Area from Evonik Steag GmbH on January 03, 2001 for $45.29 million. The company is ultimately controlled by the Beijing Economic & Technology Development Area. The company was founded in 1984 by Roger A. Carolin, Huw Kenton Thomas, Christopher Frank McConnell.

Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.

Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA.

HandyLab, Inc. develops and manufactures novel clinical diagnostic testing products. It serves medical, industrial and bio-defense markets. The company was founded by Kalyan Handique and Sundaresh Brahmasandra in 2000 and is headquartered in Plymouth, MI.

NXThera, Inc. provides technology platform to treat endourological conditions. It develops medical devices to treat patients suffering from urologic conditions, such as benign prostatic hyperplasia (BPH), prostate cancer, and kidney cancer. The company was founded by John H. Shadduck and Michael Hoey in 2008 and is headquartered in Maple Grove, MN.

Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Greenwich Pharmaceuticals, Inc. is an American company that specializes in commercial physical research.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Lurie Holdings Inc (Lurie Holdings) is a venture capital subsidiary of Ann & Robert H. Lurie Family Foundation founded in 1995. The firm is headquartered in Chicago, Illinois.

Kodak Versamark, Inc. designs and manufactures printers and other electronic equipments. It provides imprinting product systems used by commercial printers and promailers to print variable information on off line basis. It is headquartered in Dayton, OH.

Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington.

YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA.

Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany.

Wellness Coaches USA LLC provides onsite and face-to-face wellness coaching. The firm offers human interaction, coaching interaction, coaching process and issue, injury prevention, and resource integration services. It serves government, healthcare, hospitality, manufacturing, office and professional, publishing, and transportation and distribution customers. The company was in 2002 and it is headquartered in Blue Bell, PA.

Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA.

Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.